Short-term modulation of extracellular signal-regulated kinase 1/2 and stress-activated protein kinase/c-Jun NH2-terminal kinase in pancreatic islets by glucose and palmitate: Possible involvement of ceramide

Pancreas

Volumn 38, Issue 5, 2009, Pages 585-592

  Nogueira, Tatiane C A ^a   Graciano, Maria Fernanda R ^a   Anhê, Gabriel F ^a   Curi, Rui ^a   Bordin, Silvana ^a   Carpinelli, Angelo R ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Ceramide; ERK1 2; Glucose; Palmitate; Pancreatic islets; SAPK JNK

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CERAMIDE; FUMONISIN B1; GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PALMITIC ACID; SERINE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME REGULATION; FEMALE; GENE EXPRESSION; IMMUNOBLOTTING; LIPOGENESIS; NONHUMAN; ONCOGENE C FOS; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VIRUS ONCOGENE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CHROMONES; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION; GENES, IMMEDIATE-EARLY; GLUCOSE; IMMUNOBLOTTING; ISLETS OF LANGERHANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 4; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MORPHOLINES; PALMITATES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS;

EID: 67651085270     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31819fef03     Document Type: Article

References (55)

1. Prentki M, Nolan CJ. Islet beta cell failure in type 2 diabetes. J Clin Invest. 2006;116(7):1802-1812.
2. Srinivasan S, Bernal-Mizrachi E, Ohsugi M, et al. Glucose promotes pancreatic islet beta-cell survival through a PI 3-kinase/Akt-signaling pathway. Am J Physiol Endocrinol Metab. 2002;283(4):E784-793.
3. Lingohr MK, Buettner R, Rhodes CJ. Pancreatic beta-cell growth and survival: a role in obesity-linked type 2 diabetes? Trends Mol Med. 2002;8:375-384.
4. Nogueira TC, Anhê GF, Carvalho CR, et al. Involvement of phosphatidylinositol-3 kinase/AKT/PKCX/L pathway in the effect of palmitate on glucose-induced insulin secretion. Pancreas. 2008;37(3): 309-315.
5. Longuet C, Broca C, Costes S, et al. Extracellularly regulated kinases 1/2 (p44/42 mitogen-activated protein kinases) phosphorylate synapsin I and regulate insulin secretion in theMIN6 beta-cell line and islets of Langerhans. Endocrinology. 2005;146:643-654.
6. Maedler K, Schulthess FT, Bielman C, et al. Glucose and leptin induce apoptosis in human beta-cells and impair glucose-stimulated insulin secretion through activation of c-Jun N-terminal kinases. FASEB J. 2008;22(6):1905-1913.
7. Paraskevas S, Aikin R, Maysinger D, et al. Modulation of JNK and p38 stress activated protein kinases in isolated islets of Langerhans: insulin as an autocrine survival signal. Ann Surg. 2001;233(1):124-133.
8. Lawrence MC, Jivan A, Shao C, et al. The roles of MAPKs in disease. Cell Res. 2008;18(4):436-442.
9. Basu S, Kolesnick R. Stress signals for apoptosis: ceramide and c-Jun kinase. Oncogene. 1998;17:3277-3285.
10. Lawrence M, Shao C, Duan L, et al. The protein kinases ERK1/2 and their roles in pancreatic beta cells. Acta Physiol (Oxf). 2008;192(1):11-17.
11. Lopes JP, Oliveira SM, Soares Fortunato J. Oxidative stress and its effects on insulin resistance and pancreatic beta-cells dysfunction: relationship with type 2 diabetes mellitus complications. Acta Med Port. 2008;21(3):293-302.
12. Susini S, Roche E, Prentki M, et al. Glucose and glucoincretin peptides synergize to induce c-fos, c-jun, junB, zif-268, and nur-77 gene expression in pancreatic beta (INS-1) cells. FASEB J. 1998;J12:1173-1182.
13. Roche E, Buteau J, Aniento I, et al. Palmitate and oleate induce the immediate-early response genes c-fos and nur-77 in the pancreatic beta-cell line INS-1. Diabetes. 1999;48(10):2007-2014.
14. Glauser DA, Brun T, Gauthier BR, et al. Transcriptional response of pancreatic beta cells to metabolic stimulation: large scale identification of immediate-early and secondary response genes. BMC Mol Biol. 2007;8:54.
15. Glauser DA, Schlegel W. Mechanisms of transcriptional regulation underlying temporal integration of signals. Nucleic Acids Res. 2006;34:5175-5183.
16. Henderson E, Stein R. c-jun inhibits transcriptional activation by the insulin enhancer, and the insulin control element is the target of control. Mol Cell Biol. 1994;14(1):655-662.
17. Glauser DA, Schlegel W. Sequential actions of ERK1/2 on the AP-1 transcription factor allow temporal integration of metabolic signals in pancreatic beta cells. FASEB J. 2007;21(12):3240-3249.
18. Kelpe CL, Moore PC, Parazzoli SD, et al. Palmitate inhibition of insulin gene expression is mediated at the transcriptional level via ceramide synthesis. J Biol Chem. 2003;278(32):30015-30021.
19. Sjöholm A. Ceramide inhibits pancreatic beta-cell insulin production and mitogenesis and mimics the actions of interleukin-1 beta. FEBS Lett. 1995;367(3):283-286.
20. Hannun YA. Functions of ceramide in coordinating cellular responses to stress. Science. 1996;274(5294):1855-1859.
21. Ruvolo PP. Intracellular signal transduction pathways activated by ceramide and its metabolites. Pharmacol Res. 2003;47(5):383-392.
22. Carpinelli AR, Curi R, Malaisse WJ. Long-term regulation of pancreatic B-cell responsiveness to D-glucose by food availability, feeding schedule, and diet composition. Physiol Behav. 1992;52:1193-1196.
23. Carpinelli AR, Picinato MC, Stevanato E, et al. Insulin secretion induced by palmitateVa process fully dependent on glucose concentration. Diabetes Metab. 2002;28(6):3S37-44; discussion 3S108-112.
24. Powell GL, Tippett PS, Kiorpes TC, et al. Fatty acyl CoA as an effector molecule in metabolism. Fed Proc. 1985;44:81-84.
25. Schmitz-Peiffer C, Craig DL, Biden TJ. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem. 1999;274(34):24202-24210.
26. Soltys CL, Buchholz L, Gandhi M, et al. Phosphorylation of cardiac protein kinase B is regulated by palmitate. Am J Physiol Heart Circ Physiol. 2002;283:H1056-H1064.
27. Ahn EH, Schroeder JJ. Sphinganine causes early activation of JNK and p38 MAPK and inhibition of AKT activation in HT-29 human colon cancer cells. Anticancer Res. 2006;26(1A):121-127.
28. Shaulian E, Karin M. AP-1 in cell proliferation and survival. Oncogene. 2001;20(19):2390-2400.
29. Haber EP, Procópio J, Carvalho CR, et al. New insights into fatty acid modulation of pancreatic beta-cell function. Int Rev Cytol. 2006;248:1-41.
30. Butler AE, Janson J, Bonner-Weir S, et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52:102-110.
31. Shen YH, Godlewski J, Zhu J, et al. Cross-talk between JNK/SAPK and ERK/MAPK pathways: sustained activation of JNK blocks ERK activation by mitogenic factors. J Biol Chem. 2003;278(29): 26715-26721.
32. Xia ZM, Dickens J, Raingeaud RJ, et al. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 1995;270:1326-1331.
33. Benes C, Roisin MP, Van Tan H, et al. Rapid activation and nuclear translocation of mitogen-activated protein kinases in response to physiological concentration of glucose in the MIN6 pancreatic beta cell line. J Biol Chem. 1998;273(25):15507-15513.
34. Longuet C, Broca C, Costes S, et al. Extracellularly regulated kinases 1/2 (p44/42 mitogen-activated protein kinases) phosphorylate synapsin I and regulate insulin secretion in the MIN6 beta-cell line and islets of Langerhans. Endocrinology. 2005;146:643-654.
35. Usui I, Haruta T, Takata Y, et al. Differential effects of palmitate on glucose uptake in rat-1 fibroblasts and 3T3-L1 adipocytes. Horm Metab Res. 1999;31:546-552.
36. Massao-Hirabara S, de Oliveira Carvalho CR, Mendonça JR, et al. Palmitate acutely raises glycogen synthesis in rat soleus muscle by a mechanism that requires its metabolization (Randle cycle). FEBS Lett. 2003;541(1-3):109- 114.
37. Cousin SP, Hugl SR, Wrede CE, et al. Free fatty acidYinduced inhibition of glucose and insulin-like growth factor IYinduced deoxyribonucleic acid synthesis in the pancreatic beta-cell line INS-1. Endocrinology. 2001;142:229-240.
38. Evans JL, Goldfine ID, Maddux BA, et al. Are oxidative stressYactivated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes. 2003;52(1):1-8.
39. Kaneto H, Nakatani Y, Kawamori D, et al. Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic beta-cell dysfunction and insulin resistance. Int J Biochem Cell Biol. 2006;38(5Y6):782-793.
40. Gao Z, Zhang X, Zuberi A, et al. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes. Mol Endocrinol. 2004;18(8):2024-2034.
41. Saraswathi V, Hasty AH. The role of lipolysis in mediating the pro-inflammatory effects of very low density lipoproteins in mouse peritoneal macrophages. J Lipid Res. 2006;47(7):1406-1415.
42. Lawlor MA, Alessi DR. PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J Cell Sci. 2001;114:2903-2910.
43. Aikin R, Maysinger D, Rosenberg L. Cross-talk between phosphatidylinositol 3-kinase/AKT and c-Jun NH2-terminal kinase mediates survival of isolated human islets. Endocrinology. 2004; 145(10):4522-4531.
44. Barthwal MK, Sathyanarayana P, Kundu CN, et al. Negative regulation of mixed lineage kinase 3 by protein kinase B/AKT leads to cell survival. J Biol Chem. 2003;278:3897-3902.
45. Kim AH, Yano H, Cho H, et al. Akt1 regulates a JNK scaffold during excitotoxic apoptosis. Neuron. 2002;35:697-709.
46. Park HS, Kim MS, Huh SH, et al. Akt (protein kinase B) negatively regulates SEK1 by means of protein phosphorylation. J Biol Chem. 2002;277:2573-2578.
47. Leslie NR, Biondi RM, Alessi DR. Phosphoinositide-regulated kinases and phosphoinositide phosphatases. Chem Rev. 2001;101: 2365-2380.
48. Pearson G, Robinson F, Beers Gibson T, et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001;22(2):153-183.
49. Ruvolo PP. Intracellular signal transduction pathways activated by ceramide and its metabolites. Pharmacol Res. 2003;47(5):383-392.
50. Zheng W, Kollmeyer J, Symolon H, et al. Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. Biochim Biophys Acta. 2006;1758(12): 1864-1884.
51. Prentki M, Fischer S, Glennon MC, et al. Malonyl-CoA and long chain acyl-CoA as metabolic coupling factors in nutrient-induced insulin secretion. J Biol Chem. 1992;267:5802-5810.
52. Webb GC, Akbar MS, Zhao C. Expression profiling of pancreatic beta cells: glucose regulation of secretory and metabolic pathway genes. Proc Natl Acad Sci U S A. 2000;97:5773-5778.
53. Xiao J, Gregersen S, Kruhoffer M, et al. The effect of chronic exposure to fatty acids on gene expression in clonal insulin-producing cells: studies using high density oligonucleotide microarray. Endocrinology. 2001;142:4777-4784.
54. Kreisberg JI, Radnik RA, Ayo SH, et al. High glucose elevates c-fos and c-jun transcripts and proteins in mesangial cell cultures. Kidney Int. 1994;46:105-112.
55. Yao A, Takahashi T, Aoyagi T, et al. Immediate-early gene induction and MAP kinase activation during recovery from metabolic inhibition in cultured cardiac myocytes. J Clin Invest. 1995;96:69-77.